Abstract:2577 Background: T-cell receptor (TCR) repertoire represents an overall immune condition which is closely related to pathogens- or tumor-associated T cell responses. Increasing evidence suggests that TCR repertoire is expected to undergo cancer-specific changes during tumorigenesis, supporting that TCR characteristics can serve as novel markers to indicate early cancer progression. Here, we performed a systematic T cell repertoire analysis in lung cancer. We identified cancer-enriched TCR signatures and constructed a comprehensive lung cancer database integrating TCR diversity, tumor mutational profiles, immune markers expression and HLA genotypes. Methods: A total of 988 tissue samples and 3,360 blood samples were obtained from patients with lung cancer, in addition to 2,699 blood samples from healthy individuals. Multiplex-PCR-based sequencing of the CDR3 regions of TCR-β chains was applied to the tissue and blood samples. TCR repertoires were analyzed using MiXCR and VDJtools. Whole exome sequencing was performed on partial tumor tissues to profile the mutational landscape and HLA genotypes. An in-house pipeline, considering the frequency and distribution of CDR3, was utilized to identify cancer-enriched CDR3 sequences. The PD-L1 expression was evaluated and quantified using CPS. Furthermore, an enrich score was developed to measure the content of cancer-related TCRs by aligning against the built cancer-enriched CDR3 dataset. Spearman's rank correlation was used to assess relationships between variables. Results: Lung cancer exhibited significantly lower Shannon index, Simpson index and evenness index in TCR repertoire (p<0.001), both in tissue and blood samples, when compared with healthy blood samples. Approximate 3% T-cell clonotypes within lung tissues were detected in blood TCR repertoires. A correlation was observed between the decreased TCR diversity and a higher tumor mutational burden (TMB)(r = -0.15, p < 0.01), as well as a higher variant allele frequency (VAF) (r = -0.19, p < 0.01). In this study, 3,652 and 3,840 CDR3 sequences were identified to be enriched in lung cancer tissue and blood respectively. A significant difference in cancer-enriched score was observed between cancer and healthy TCR repertoires (p < 0.001). The cancer-enriched score showed a significant positive correlation with TMB, particularly in TP53- mutant tumors (r = 0.27, p < 0.001). A higher CPS (PD-L1) was associated with a higher cancer-enriched score (r = 0.18 ,p < 0.01). Conclusions: Cancer-related T-cell clonotypes in the tumor microenvironment and peripheral blood informs the changes in anti-tumor responses, supporting the potential application of TCR signatures in early cancer detection. This study identified the lung cancer-related TCR signatures and provided a comprehensive lung cancer TCR database, revealing the relationship between TCR characteristics and mutational profiles. Clinical trial information: ChiCTR2200055761.

TCR-L: an analysis tool for evaluating the association between the T-cell receptor repertoire and clinical phenotypes

TCRpred: incorporating T-cell receptor repertoire for clinical outcome prediction

Analysis of the Repertoire Features of TCR Beta Chain CDR3 in Human by High-Throughput Sequencing

Disease associated human TCR characterization by deep-learning framework TCR-DeepInsight

T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy

Large-scale statistical mapping of T-cell receptor sequences to Human Leukocyte Antigens

Detecting T-cell receptors involved in immune responses from single repertoire snapshots

The conserved T cell receptor repertoire observed in patients with systemic lupus erythematosus

Integrating T-cell Receptor and Transcriptome for Large-Scale Single-Cell Immune Profiling Analysis

An Ultrasensitive T-cell Receptor Detection Method for TCR-Seq and RNA-Seq Data

Exploring the potential of the TCR repertoire as a tumor biomarker (Review)

Characterization of T-cell Receptor Repertoire and Correlation with Tumor Mutational Landscape in Lung Cancer.

Human TCR repertoire in cancer

TCRdb: a comprehensive database for T-cell receptor sequences with powerful search function

T-Cell Receptor Repertoire Analysis with Computational Tools-An Immunologist's Perspective

TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs

Haplotype Analysis of the TRB Locus by TCRB Repertoire Sequencing

Rapid Assessment of T-Cell Receptor Specificity of the Immune Repertoire

Mapping the functional landscape of T cell receptor repertoires by single-T cell transcriptomics

TCRosetta: a powerful server for analyzing and annotating T-cell receptor repertoire

Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencing